{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:47:37Z","timestamp":1790412457228,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011510","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000}}],"reference-count":94,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011510.pub2","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T20:47:48Z","timestamp":1540846068000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices"],"prefix":"10.1002","volume":"2018","author":[{"given":"Antony P","family":"Zacharias","sequence":"first","affiliation":[{"name":"Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Jeyaraj","sequence":"additional","affiliation":[{"name":"Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Hobolth","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Hvidovre; Gastrounit, Medical Division; Kattegaards Alle 30 Hvidovre Denmark 2650"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Bendtsen","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Hvidovre; Gastrounit, Medical Division; Kattegaards Alle 30 Hvidovre Denmark 2650"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen University Hospital Hvidovre; Gastrounit, Medical Division; Kattegaards Alle 30 Hvidovre Denmark 2650"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha Y","family":"Morgan","sequence":"additional","affiliation":[{"name":"Division of Medicine, Royal Free Campus, University College London; UCL Institute for Liver & Digestive Health; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD011510.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"A46","DOI":"10.1007\/s12664-011-0142-4","article-title":"Evaluation of treatment with carvedilol in comparison to propranolol in primary\/secondary prophylaxis of gastroesophageal variceal bleeding","volume":"30","author":"Agarwala","year":"2011","journal-title":"Indian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.1840360612","article-title":"Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Ba\u00f1ares","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1746.2002.02674.x","article-title":"Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics","volume":"17","author":"De","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12072-017-9835-9","article-title":"Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding","volume":"12","author":"Abd ElRahim","year":"2018","journal-title":"Hepatology International"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12072-016-9765-y","article-title":"Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT","volume":"11","author":"Gupta","year":"2016","journal-title":"Hepatology International"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011510.pub2-BIB0006|cit6","first-page":"A307","article-title":"Medical versus endoscopic treatment of oesophageal varices in liver cirrhosis","volume":"5","author":"Hanno","year":"2016","journal-title":"United European Gastroenterology Journal"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.dld.2013.10.013","article-title":"Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study","volume":"46","author":"Hobolth","year":"2014","journal-title":"Digestive and Liver Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/00365521.2012.666673","article-title":"Carvedilol or propranolol in portal hypertension? A randomized comparison","volume":"47","author":"Hobolth","year":"2012","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD011510.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2016.327","article-title":"A randomized, multi-center, open-label study to evaluate the efficacy of carvedilol vs. propranolol to reduce portal pressure in patients with liver cirrhosis","volume":"111","author":"Kim","year":"2016","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011510.pub2-BIB0010|cit10","first-page":"576A","article-title":"A randomized, multi-center, open-label study to evaluate the long-term effect of carvedilol versus propranolol on reduction in portal pressure in patients with cirrhosis: CARPE study","volume":"62","author":"Kim","year":"2015","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011510.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"990A","DOI":"10.1002\/hep26874","article-title":"A randomized, multi-center, phase IV open-label study to evaluate and compare the effect of carvedilol versus propranolol on reduction in portal pressure inpatients with cirrhosis: an interim analysis","volume":"58","author":"Sohn","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"11","key":"10.1002\/14651858.CD011510.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","article-title":"Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding","volume":"27","author":"Lo","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"27","key":"10.1002\/14651858.CD011510.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.11569\/wcjd.v22.i27.4146","article-title":"Short-term effect of carvedilol vs propranolol in reduction of hepatic venous pressure gradient in patients with cirrhotic portal hypertension","volume":"22","author":"Mo","year":"2014","journal-title":"World Chinese Journal of Digestology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011510.pub2-BIB0014|cit14","first-page":"S571","article-title":"The effect of carvedilol vs propranolol in patients with cirrhosis related gastroesophageal varices for secondary prophylaxis: a randomized controlled trial","volume":"12","author":"Wei","year":"2018","journal-title":"Hepatology International"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective beta-blocker with intrinsic anti- alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis","volume":"30","author":"Ba\u00f1ares","year":"1999","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"S1","key":"10.1002\/14651858.CD011510.pub2-BIB0016|cit16","first-page":"252","article-title":"Effectiveness of beta-blockers (BB) in primary prevention of esophageal varices (EV) bleeding in patients with cirrhosis: a prospective evaluation by hepatic venous pressure gradient (HVPG) measurement","volume":"66","author":"Bonaccorso","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.dld.2014.08.029","article-title":"Effectiveness of beta-blocker in primary prevention of variceal bleeding in patients with cirrhosis: a prospective evaluation by hepatic venous pressure gradient measurement","volume":"46","author":"Butera","year":"2014","journal-title":"Digestive and Liver Disease"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD011510.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1016\/S0168-8278(16)00361-5","article-title":"Effectiveness of beta-blockers in primary prevention of bleeding: a comparison of propranolol vs. carvedilol by HVPG","volume":"64","author":"Calvaruso","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD011510.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1572-0241.2004.40179.x","article-title":"Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis","volume":"99","author":"Lin","year":"2004","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0020|cit20","unstructured":"NCT01059396 Study on \u00df-blockers to prevent decompensation of cirrhosis with HTPortal (PREDESCI) clinicaltrials.gov\/ct2\/show\/NCT01059396"},{"issue":"11","key":"10.1002\/14651858.CD011510.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"issue":"11","key":"10.1002\/14651858.CD011510.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/medicina49110073","article-title":"Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis","volume":"49","author":"Silkauskaite","year":"2013","journal-title":"Medicina"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0023|cit23","unstructured":"Chen S The effect of carvedilol vs propranolol in cirrhotic patients with variceal bleeding ClinicalTrials.gov Identifier: NCT02385422"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1665-2681(19)30849-X","article-title":"Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: systematic review and meta-analysis","volume":"13","author":"Aguilar-Olivos","year":"2014","journal-title":"Annals of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011510.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2007.01191.x","article-title":"Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis","volume":"102","author":"Albillos","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11894-012-0308-y","article-title":"Natural history of cirrhosis","volume":"15","author":"Asrani","year":"2013","journal-title":"Current Gastroenterology Reports"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0027|cit27","first-page":"76","article-title":"Gastric varices","volume-title":"Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies","author":"Sarin","year":"2001"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0016-5107(81)73224-3","article-title":"Prediction of variceal hemorrhage by esophageal endoscopy","volume":"27","author":"Beppu","year":"1981","journal-title":"Gastrointestinal Endoscopy"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v23.i1.1","article-title":"Clinical role of non-invasive assessment of portal hypertension","volume":"23","author":"Bolognesi","year":"2017","journal-title":"World Journal of Gastroenterology"},{"issue":"9361","key":"10.1002\/14651858.CD011510.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of variceal rebleeding","volume":"361","author":"Bosch","year":"2003","journal-title":"Lancet"},{"issue":"S1","key":"10.1002\/14651858.CD011510.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.CIR.102.6.677","article-title":"Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production","volume":"102","author":"Broeders","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Brown P Brunnhuber K Chalkidou K Chalmers I Clarke M Fenton M How to formulate research recommendations BMJ (Clinical Research Ed.) 2006 804 6","DOI":"10.1136\/bmj.38987.492014.94"},{"issue":"12","key":"10.1002\/14651858.CD011510.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1080\/00365520600780403","article-title":"Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes","volume":"41","author":"Bruha","year":"2006","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011510.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"104-15","DOI":"10.1111\/liv.13277","article-title":"Prevention and treatment of variceal haemorrhage in 2017","volume":"37","author":"Brunner","year":"2017","journal-title":"Liver International"},{"issue":"7","key":"10.1002\/14651858.CD011510.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension","volume":"11","author":"Cal\u00e9s","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20339","article-title":"Improved survival after variceal bleeding in patients with cirrhosis over the past two decades","volume":"40","author":"Carbonell","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1572-0241.2003.07294.x","article-title":"Improved patient survival after acute variceal bleeding: a multicenter, cohort study","volume":"98","author":"Chalasani","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011510.pub2-BIB0039|cit39","first-page":"961","article-title":"The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis","volume":"14","author":"Chen","year":"2015","journal-title":"Patient Preference and Adherence"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach","volume":"19","author":"D'Amico","year":"1999","journal-title":"Seminars in Liver Disease"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico","year":"2003","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1002\/14651858.CD011510.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D'Amico","year":"2006","journal-title":"Gastroenterology"},{"issue":"7109","key":"10.1002\/14651858.CD011510.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0168-8278(96)80296-0","article-title":"Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis","volume":"25","author":"Forrest","year":"1996","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.1840110212","article-title":"Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis","volume":"11","author":"Garc\u00eda-Pag\u00e1n","year":"1990","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0016-5085(01)81028-3","article-title":"Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive \u00df-blockers","volume":"121","author":"Garc\u00eda-Pag\u00e1n","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/jhep.2003.50211","article-title":"Propranolol plus placebo versus propranolol plus isosorbide-5-mononitratein the prevention of a first variceal bleed: a double-blind RCT","volume":"37","author":"Garc\u00eda-Pag\u00e1n","year":"2003","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0048|cit48","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"5","key":"10.1002\/14651858.CD011510.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1002\/14651858.CD011510.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2254-61","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1002\/14651858.CD011510.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1592\/phco.24.1.94.34805","article-title":"Evaluation of carvedilol for the treatment of portal hypertension","volume":"24","author":"Hemstreet","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0054|cit54","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0055|cit55","unstructured":"Higgins JP Altman DG Sterne JA (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from: www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1478-3231.2009.02169.x","article-title":"The recent reduction in mortality from bleeding oesophageal varices is primarily observed from days 1 to 5","volume":"30","author":"Hobolth","year":"2010","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0057|cit57","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Iwakiri Y Shah V Rockey DC Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions Journal of Hepatology 2014 912 24","DOI":"10.1016\/j.jhep.2014.05.047"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02468653","article-title":"The general rules for recording endoscopic findings on esophageal varices","volume":"10","author":"Japanese Research Society for Portal Hypertension","year":"1980","journal-title":"Japanese Journal of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gie.2006.08.023","article-title":"Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database","volume":"65","author":"Kovalak","year":"2007","journal-title":"Gastrointestinal Endoscopy"},{"issue":"8226","key":"10.1002\/14651858.CD011510.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0140-6736(81)91617-2","article-title":"Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients","volume":"1","author":"Lebrec","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD011510.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"e010902","DOI":"10.1136\/bmjopen-2015-010902","article-title":"Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.21945","article-title":"A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage","volume":"47","author":"Longacre","year":"2008","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"10","key":"10.1002\/14651858.CD011510.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome: systematic review with meta-analysis","volume":"44","author":"Lundh","year":"2018","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0065|cit65","unstructured":"Methodological Expectations of Cochrane Intervention Reviews (MECIR) www.editorial-unit.cochrane.org\/mecir"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2006.08.011","article-title":"Molecular and structural basis of portal hypertension","volume":"10","author":"Moreau","year":"2006","journal-title":"Clinics in Liver Disease"},{"issue":"15","key":"10.1002\/14651858.CD011510.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study","volume":"319","author":"The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD011510.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000035.pub2","article-title":"Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions","author":"Page","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-2007-1021560","article-title":"Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial","volume":"14","author":"Paquet","year":"1982","journal-title":"Endoscopy"},{"issue":"22","key":"10.1002\/14651858.CD011510.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","article-title":"Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group","volume":"324","author":"Poynard","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0073|cit73","unstructured":"Qu CX The preliminary research of the short-term reduction of hepatic vein pressure gradient to predict the long-term curative effect of beta-blockers Shandong University 2012"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0074|cit74","unstructured":"Ren RR The comparison of recent curative effect on the reduction of hepatic vein pressure gradient in patients with cirrhosis Shandong University 2012"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0075|cit75","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"35","key":"10.1002\/14651858.CD011510.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0080|cit80","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"4","key":"10.1002\/14651858.CD011510.pub2-BIB0081|cit81","first-page":"353","article-title":"Effects of the alpha-\/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension","volume":"47","author":"Sekiyama","year":"1997","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0168-8278(99)80108-1","article-title":"Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis","volume":"30","author":"Stanley","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011510.pub2-BIB0084|cit84","unstructured":"Stata Corp, Texas, USA STATA 13 2007"},{"issue":"1","key":"10.1002\/14651858.CD011510.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3350\/cmh.2014.20.1.6.","article-title":"Hepatic venous pressure gradient: clinical use in chronic liver disease","volume":"20","author":"Suk","year":"2014","journal-title":"Clinical and Molecular Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD011510.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MEG.0b013e3281bcb784","article-title":"Cost of treatment of oesophageal variceal bleeding in patients with cirrhosis in France: results of a French survey","volume":"19","author":"Thabut","year":"2007","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD011510.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.dld.2005.02.009","article-title":"Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients","volume":"37","author":"Thalheimer","year":"2005","journal-title":"Digestive and Liver Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011510.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1053\/j.gastro.2007.10.028","article-title":"How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers","volume":"133","author":"Thalheimer","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","article-title":"Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension","volume":"16","author":"Tripathi","year":"2002","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD011510.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/MEG.0b013e3283367a99","article-title":"The role of carvedilol in the management of portal hypertension","volume":"22","author":"Tripathi","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD011510.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrgastro.2009.198","article-title":"Gastrointestinal bleeding: carvedilol-the best beta-blocker for primary prophylaxis?","volume":"6","author":"Tsochatzis","year":"2009","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011510.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","article-title":"Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis","volume":"101","author":"Turnes","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011510.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011510.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011510","article-title":"Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosis","author":"Hobolth","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011510.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:56:58Z","timestamp":1628549818000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011510.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":94,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011510.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]}}}